Literature DB >> 22334167

Immunodetection analysis of muscular dystrophies in Mexico.

Benjamín Gómez-Díaz1, Haydeé Rosas-Vargas, Bladimir Roque-Ramírez, Pedro Meza-Espinoza, Luis A Ruano-Calderón, Francisca Fernández-Valverde, Deyanira Escalante-Bautista, Rosa E Escobar-Cedillo, Laura Sánchez-Chapul, Steven Vargas-Cañas, Luz B López-Hernández, Eliganty Bahena-Martínez, Alexandra B Luna-Angulo, Patricia Canto, Ramón M Coral-Vázquez.   

Abstract

INTRODUCTION: The muscular dystrophies (MDs) result from perturbations in the myofibers. These alterations are induced in part by mechanical stress due to membrane cell fragility, disturbances in mechanotransduction pathways, muscle cell physiology, and metabolism.
METHODS: We analyzed 290 biopsies of patients with a clinical diagnosis of muscular dystrophy. Using immunofluorescence staining, we searched for primary and secondary deficiencies of 12 different proteins, including membrane, costamere, cytoskeletal, and nuclear proteins. In addition, we analyzed calpain-3 by immunoblot.
RESULTS: We identified 212 patients with varying degrees of protein deficiencies, including dystrophin, sarcoglycans, dysferlin, caveolin-3, calpain-3, emerin, and merosin. Moreover, 78 biopsies showed normal expression of all investigated muscle proteins. The frequency rates of protein deficiencies were as follows: 52.36% dystrophinopathies; 18.40% dysferlinopathies; 14.15% sarcoglycanopathies; 11.32% calpainopathies; 1.89% merosinopathies; 1.42% caveolinopathies; and 0.47% emerinopathies. Deficiencies in lamin A/C and telethonin were not detected.
CONCLUSION: We have described the frequency of common muscular dystrophies in Mexico.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22334167     DOI: 10.1002/mus.22314

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  A novel noncontiguous duplication in the DMD gene escapes the 'reading-frame rule'.

Authors:  Luz Berenice López-Hernández; Benjamín Gómez-Díaz; Eliganty Bahena-Martínez; Teresa Neri-Gómez; Alejandra Camacho-Molina; Luis A Ruano-Calderón; Silvia García; Ramón M Coral-Vázquez
Journal:  J Genet       Date:  2014-04       Impact factor: 1.166

Review 2.  Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review.

Authors:  Cecilia Contreras-Cubas; Francisco Barajas-Olmos; Maria Inés Frayre-Martínez; Georgina Siordia-Reyes; Claudia C Guízar-Sánchez; Humberto García-Ortiz; Lorena Orozco; Vicente Baca
Journal:  BMC Med Genomics       Date:  2022-06-20       Impact factor: 3.622

3.  Clinical, Neurophysiological, Radiological, Pathological, and Genetic Features of Dysferlinopathy in Saudi Arabia.

Authors:  Norah Alharbi; Rawan Matar; Edward Cupler; Hindi Al-Hindi; Hatem Murad; Iftteah Alhomud; Dorota Monies; Ali Alshehri; Mossaed Alyahya; Brian Meyer; Saeed Bohlega
Journal:  Front Neurosci       Date:  2022-02-22       Impact factor: 4.677

4.  Epidemiological and Molecular Characterization of a Mexican Population Isolate with High Prevalence of Limb-Girdle Muscular Dystrophy Type 2A Due to a Novel Calpain-3 Mutation.

Authors:  Carlos A Pantoja-Melendez; Antonio Miranda-Duarte; Bladimir Roque-Ramirez; Juan C Zenteno
Journal:  PLoS One       Date:  2017-01-19       Impact factor: 3.240

5.  Genetic variability in Iranian limb-girdle muscular dystrophy type 2B patients: An evidence of a founder effect.

Authors:  Marzieh Mojbafan; Shirzadeh Tina; Fatemeh Zafarghandi Motlagh; Andrei Surguchov; Yalda Nilipour; Sirous Zeinali
Journal:  Mol Genet Genomic Med       Date:  2019-11-06       Impact factor: 2.183

6.  Disease Progression and Mutation Pattern in a Large Cohort of LGMD R1/LGMD 2A Patients from India.

Authors:  Valakunja H Ganaraja; Kiran Polavarapu; Mainak Bardhan; Veeramani Preethish-Kumar; Shingavi Leena; Ram M Anjanappa; Seena Vengalil; Saraswati Nashi; Gautham Arunachal; Swetha Gunasekaran; Dhaarini Mohan; Sanita Raju; Gopikrishnan Unnikrishnan; Akshata Huddar; Valasani Ravi-Kiran; Priya T Thomas; Atchayaram Nalini
Journal:  Glob Med Genet       Date:  2021-11-09

Review 7.  A Journey with LGMD: From Protein Abnormalities to Patient Impact.

Authors:  Dimitra G Georganopoulou; Vasilis G Moisiadis; Firhan A Malik; Ali Mohajer; Tanya M Dashevsky; Shirley T Wuu; Chih-Kao Hu
Journal:  Protein J       Date:  2021-06-10       Impact factor: 2.371

Review 8.  Limb-girdle muscular dystrophies: where next after six decades from the first proposal (Review).

Authors:  Omar A Mahmood; Xin Mei Jiang
Journal:  Mol Med Rep       Date:  2014-03-13       Impact factor: 2.952

9.  Limb-girdle muscular dystrophy subtypes: First-reported cohort from northeastern China.

Authors:  Omar Abdulmonem Mahmood; Xinmei Jiang; Qi Zhang
Journal:  Neural Regen Res       Date:  2013-07-15       Impact factor: 5.135

10.  Predominance of Dystrophinopathy Genotypes in Mexican Male Patients Presenting as Muscular Dystrophy with A Normal Multiplex Polymerase Chain Reaction DMD Gene Result: A Study Including Targeted Next-Generation Sequencing.

Authors:  Miguel Angel Alcántara-Ortigoza; Miriam Erandi Reyna-Fabián; Ariadna González-Del Angel; Bernardette Estandia-Ortega; Cesárea Bermúdez-López; Gabriela Marisol Cruz-Miranda; Matilde Ruíz-García
Journal:  Genes (Basel)       Date:  2019-10-29       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.